Osteosarcoma

Pediatric Clinics of North America

Volumn 44, Issue 4, 1997, Pages 973-989

  Meyers, P A ^a   Gorlick, R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE GROWTH; CHILD; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; EVOLUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; OSTEOSARCOMA; PAGET BONE DISEASE; RADIATION EXPOSURE; RETINOBLASTOMA; REVIEW;

EID: 0030754370     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(05)70540-X     Document Type: Article

References (81)

1. D.H. Abramson R.M. Ellsworth F.D. Kitchin Second nonocular tumors in retinoblastoma survivors: Are they radiation-induced? Ophthalmology 91 1984 1351 1355
2. G. Bacci P. Ruggieri P. Picci Changing pattern of relapse in osteosarcoma of the extremities treated with adjuvant and neoadjuvant chemotherapy J Chemother 7 1995 230 239
3. E.S. Baum P. Gaynon L. Greenberg Phase II study of cis-dichlorodiammineplatinum (II) in childhood osteosarcoma: Children's Cancer Study Group report Cancer Treatment Rep 63 1979 1621 1627
4. E. Beattie N. Martini G. Rosen The management of pulmonary metastases in children with osteogenic sarcoma with surgical resection combined with chemotherapy Cancer 35 1975 618 621
5. C. Caluser H. Macapinlac J. Healey The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumors Clin Nucl Med 17 1992 565 572
6. S.K. Carter Adjuvant chemotherapy in osteogenic sarcoma: The triumph that isn't? J Clin Oncol 2 1984 152 156
7. E.P. Cortes J.F. Holland O. Glidewall Amputation and Adriamycin in primary osteosarcoma: A 5 year report Cancer Treatment Rep 62 1978 271 277
8. E.P. Cortes J.F. Holland J.J. Wang Amputation and Adriamycin in primary osteosarcoma N Engl J Med 291 1974 998 1000
9. E.P. Cortes J.F. Holland J.J. Wang Doxorubicin in disseminated osteosarcoma J Am Med Assoc 221 1972 1132 1138
10. D.C. Dahlin M.B. Coventry Osteosarcoma: A study of six hundred cases J Bone Joint Surg 49 1967 101 110
11. A.M. Davis R.S. Bell P.J. Goodwin Prognostic factors in osteosarcoma: A critical review J Clin Oncol 12 1994 423 431
12. N.M. Davis P.J. Livesley S.R. Cannon Recurrence of an osteosarcoma in a needle biopsy track Br J Bone Joint Surg 75 1993 977 978
13. L. Diller J. Kassel C.E. Nelson p53 functions as a cell cycle control protein in osteosarcomas Mol Cell Biol 10 1990 5772 5781
14. F. Eilber A. Giuliano J. Eckardt Adjuvant chemotherapy for osteosarcoma: A randomized prospective trial J Clin Oncol 5 1987 21 26
15. J.H. Edmondson S.J. Green J.C. Ivins A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma J Clin Oncol 2 1984 152 156
16. M.E. Ewen The cell cycle and the retinoblastoma protein family Cancer Metast Rev 13 1994 45 66
17. J.L. Fidler G. Poste Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease Springer Semin Immunopathol 5 1982 161 174
18. C. Freeman R. Gledhill L. Chevalier Osteogenic sarcoma following treatment with megavoltage radiation and chemotherapy for bone tumors in children Med Pediatr Oncol 8 1980 375 382
19. M. Gasparini J. Rouesse A. Van Oosterom Phase II study of cisplatin in advanced osteogenic sarcoma Cancer Treatment Rep 69 1985 211 213
20. A. Goorin A. Baker P. Gieser No evidence for improved event free survival (EFS) with presurgical chemotherapy (PRE) for non-metastatic extremity osteosarcoma (OGS): Preliminary results of randomized Pediatric Oncology Group (POG) trial 8651 [abstract] Proc Am Soc Clin Oncol 6 1995 329 337
21. A.M. Goorin J.J. Shuster A. Baker Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study J Clin Oncol 9 1991 600 605
22. M.F. Hansen W.K. Cavenee Tumor suppressors: Recessive mutations that lead to cancer Cell 53 1988 172 173
23. M.B. Harris A.B. Cantor A.M. Goorin Treatment of osteosarcoma with ifosfamide: Comparison of response in pediatric patients with recurrent disease versus patients previously untreated: A Pediatric Oncology Group study Med Pediatr Oncol 24 1995 87 92
24. T. Harrist A. Schiller R. Trelstad Thorotrast associated sarcoma of bone: A case report and review of the literature Cancer 44 1979 2049 2058
25. R. Haselow M. Nesbit L. Dehner Second neoplasms following megavoltage radiation in a pediatric population Cancer 42 1978 1185 1191
26. H.C. Holscher J.L. Bloem H.J. van der Woude Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy? Clin Radiol 50 1995 384 390
27. A. Huvos Osteogenic sarcoma A. Huvos Bone Tumors: Diagnosis, Treatment and Prognosis ed 2 1991 WB Saunders Philadelphia 85 156
28. N. Jaffe S. Farber D. Traggis Favorable response of metastatic osteogenic sarcoma to pulse high dose methotrexate with citrovorum rescue and radiation therapy Cancer 31 1973 1367 1373
29. N. Jaffe E. Frei D. Traggis H. Watts Weekly high-dose methotrexate-citrovorum factor in osteogenic sarcoma Cancer 39 1977 45 50
30. N. Jaffe E. Frei H. Watts D. Traggis High dose methotrexate in osteogenic sarcoma: A 5-year experience Cancer Treatment Rep 62 1978 259 264
31. E.S. Kleinerman Biological therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide Hematol Oncol Clin North Am 9 1995 927 938
32. E.S. Kleinerman K.L. Erickson A.J. Schroit Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide Cancer Res 43 1983 2010 2014
33. E.S. Kleinerman J.B. Gano D.A. Johnston Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma Am J Clin Oncol 18 1995 93 99
34. E.S. Kleinerman S.-F. Jia J. Griffin Phase II study of liposomal muramyl tripeptide in osteosarcoma: The cytokine cascade and monocyte activation following administration J Clin Oncol 10 1992 1310 1316
35. E.S. Kleinerman A.K. Raymond C.D. Bucana Unique histological changes in lung metastases of osteosarcoma patients following therapy with liposomal MTP-PE Cancer Immunol Immunother 34 1992 211 220
36. E.S. Kleinerman J.S. Snyder N. Jaffe Influence of chemotherapy administration of monocyte activation by liposomal MTP-PE in children with osteosarcoma J Clin Oncol 9 1991 259 267
37. M. Ladanyi C. Cha R. Lewis MDM2 gene amplification in metastatic osteosarcoma Cancer Res 55 1993 16 18
38. M. Ladanyi C.K. Park R. Lewis Sporadic amplification of the MYC gene in human osteosarcoma Diagn Mol Pathol 2 1993 163 167
39. A.J. Levine A. Chang D. Dittmer The p53 tumor suppressor gene J Lab Clin Med 123 1994 817 823
40. M.M. Lewis The use of an expandable and adjustable prosthesis in the treatment of childhood malignant bone tumors of the extremity Cancer 57 1986 499 502
41. M.P. Link A.M. Goorin M. Horowitz Adjuvant chemotherapy of high-grade osteosarcoma of the extremity Clin Orthop 270 1991 8 14
42. M.P. Link A.M. Goorin A.W. Miser The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity N Engl J Med 314 1986 1600 1606
43. J. Loutit Malignancy from radium Br J Cancer 24 1972 195 207
44. E.G. MacEwen I.D. Kurzman R.C. Rosenthal Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide J Natl Cancer Inst 81 1989 935 938
45. D. Malkin K.W. Jolly N. Barbier Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms N Engl J Med 326 1992 1309 1315
46. R.C. Marcove V. Mike J.V. Hajeh Osteosarcoma under the age of twenty-one: A review of one hundred and forty-five operative cases J Bone Joint Surg 52 1970 411 423
47. R.C. Marcove D.S. Sheth J. Healey Limb-sparing surgery for extremity sarcoma Cancer Invest 12 1994 497 504
48. J.F. McIntyre B.K. Smith-Sorensen S.H. Friend Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma J Clin Oncol 12 1994 925 930
49. W.H. Meyer M.J. Schell A.P.M. Kumar Thoracotomy for pulmonary metastatic osteosarcoma: An analysis of prognostic indicators of survival Cancer 59 1987 374 379
50. P. Meyers E. Casper A. Huvos Osteogenic sarcoma (OS): Randomized trial of intensive pre-operative (pre-op) chemo vs chemo guided by histologic response to pre-op chemo [abstract] Med Pediatr Oncol 27 1996 263
51. P.A. Meyers G. Heller J.H. Healey Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial-Sloan Kettering experience J Clin Oncol 10 1992 5 15
52. P.A. Meyers G. Heller J.H. Healey Osteogenic sarcoma with clinically detectable metastasis at initial presentation J Clin Oncol 11 1993 449 453
53. V. Mike R.C. Marcove Osteogenic sarcoma under the age of 21: Experience at Memorial Sloan-Kettering Cancer Center Progr Cancer Res Ther 6 1978 283 292
54. C.W. Miller A. Aslo A. Won Alterations of the p53, Rb, and MDM2 genes in osteosarcoma J Cancer Res Clin Oncol 122 1996 559 565
55. R. Miller Etiology of childhood bone cancer: Epidemiologic observations Rec Results Cancer Res 54 1976 50 62
56. J. Muhm L. Brown J. Crowe Comparison of whole lung tomography and computed tomography of detecting pulmonary nodules AJR Am J Radiol 131 1978 981 984
57. J.L. Murray E.S. Kleinerman J.E. Cunningham Phase I trial of liposomal muramyl tripeptide phosphatidyl-ethanolamine in cancer patients J Clin Oncol 7 1989 1915 1925
58. R. Nitschke K.A. Starling T. Vals H. Bryan Cis-diamminedichloroplatinum (NSC-119875) in childhood malignancies: A Southwest Oncology Group study Med Pediatr Oncol 4 1978 127 132
59. J.J. Ochs A.I. Freeman H.O. Douglass Cis-dichlorodiammineplatinum (II) in advanced osteogenic sarcoma Cancer Treatment Rep 62 1978 239 245
60. R.L. Page P.K. Garg S. Garg PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragment J Nucl Med 35 1994 1506 1513
61. U. Pastorini M. Gasparini L. Tavecchio The contribution of salvage surgery to the management of childhood osteosarcoma J Clin Oncol 9 1991 1357 1362
62. C. Pratt C. Howarth J. Ransom High dose methotrexate used alone and in combination for measurable primary and metastatic osteosarcoma Cancer Treatment Rep 64 1980 11 20
63. A.J. Provisor L.J. Ettinger J.B. Nachman Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: A report from the Children's Cancer Group J Clin Oncol 15 1997 76 84
64. G. Rosen B. Caparros A.G. Huvos Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy Cancer 49 1982 1221 1230
65. G. Rosen A. Huvos C. Mosende Chemotherapy and thoracotomy for metastatic osteogenic sarcoma Cancer 41 1978 841 849
66. G. Rosen R.C. Marcove A.G. Huvos Primary osteogenic sarcoma: Eight year experience with adjuvant chemotherapy J Cancer Res Clin Oncol 106 1983 55 67
67. G. Rosen R.C. Marcove B. Caparros Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery Cancer 43 1979 2163 2177
68. G. Rosen M.L. Murphy A.G. Huvos Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma Cancer 37 1976 1 11
69. S.A. Rosenberg B.A. Chabner R.C. Young Treatment of osteogenic sarcoma: I. Effect of adjuvant high dose methotrexate after amputation Cancer Treatment Rep 63 1979 739 751
70. G. Saeter J. Hoie A.E. Stenwig Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival Cancer 75 1995 1084 1093
71. E.G. Schaner A.E. Chang J.L. Doppman Comparison of computed and conventional whole lung tomography in detecting pulmonary nodules: A prospective radiologic-pathologic study Am J Radiol 131 1978 51 54
72. R.B. Scholz H. Kabisch B. Weber Studies on the RB1 gene and the p53 gene in human osteosarcomas Ped Hematol Oncol 9 1992 125 137
73. F. Sim R. Cupps D. Dahlin J. Ivins Postradiation sarcoma of bone J Bone Joint Surg 54 1972 1479 1489
74. W.F. Taylor J.C. Ivins D.C. Dahlin Osteogenic sarcoma experience at the Mayo clinic, 1963–74 Progr Cancer Res Ther 6 1978 257 269
75. W.F. Taylor J.C. Ivins D.J. Pritchard Trends and variability in survival among patients with osteosarcoma: A 7-year update Mayo Clin Proc 60 1985 91 104
76. J. Toguchida T. Yamaguchi B. Ritchie Mutation spectrum of the p53 gene in bone and soft tissue sarcomas Cancer Res 52 1992 6194 6199
77. D. Vanel M. Henry-Amar J. Lumbraso Pulmonary evaluation of patients with osteosarcoma: Roles of standard radiography, tomography, CT, scintigraphy and tomoscintigraphy AJR Am J Radiol 143 1984 519 523
78. B. Wada J. Toguchida T. Shimizu Mutation spectrum of the retinoblastoma gene in osteosarcomas Cancer Res 54 1994 3042 3048
79. K. Winkler G. Beron G. Delling Neoadjuvant chemotherapy of osteosarcoma: Results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histologic tumor response J Clin Oncol 6 1988 329 337
80. T. Yamaguchi J. Toguchida T. Yamamuro Allelotype analysis in osteosarcoma: frequent allele loss on 3q, 13q, 17q, and 18q Cancer Res 52 1992 2419 2423
81. J. Young R. Miller Incidence of malignant tumors in U.S. children J Pediatr 86 1975 254 258